Skip to main content
. 2021 Oct 1;3(1):vdab127. doi: 10.1093/noajnl/vdab127

Figure 2.

Figure 2.

The presence of EGFR/ERBB alterations was associated with favorable outcome in a cohort of 112 patients with unmethylated MGMT promoter GBM.